Ratings by Berenberg (Esther Hong)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/25/2022 | Aprea | APRE | Maintain | Buy (N/A) |
|
Details | ||
| 5/23/2022 | Concert Pharmaceuticals | CNCE | Maintain | Buy (N/A) |
|
Details | ||
| 5/20/2022 | Spero Therapeutics | SPRO | Downgrade | Hold (Buy) |
1.44 (1.64) |
13.89% | Details | |
| 4/21/2022 | Athira Pharma | ATHA | New Coverage | Buy (N/A) |
11.63 (1.95) |
-83.23% | Details | |
| 1/10/2022 | Bionomics Ltd. | BNOX | New Coverage | Buy (N/A) |
11.55 (0.93) |
-91.95% | Details | |
| 8/16/2021 | Invitation Homes | INVH | Downgrade | Hold (Buy) |
39.62 (34.45) |
-13.05% | Details | |
| 8/16/2021 | Aprea | APRE | Downgrade | Hold (Buy) |
3.65 (5.44) |
49.04% | Details | |
| 8/16/2021 | American Homes 4 Rent | AMH | Downgrade | Hold (Buy) |
40.96 (35.78) |
-12.65% | Details | |
| 6/10/2021 | Acadia Pharmaceuticals | ACAD | New Coverage | Hold (N/A) |
26.13 (17.22) |
-34.1% | Details | |
| 6/10/2021 | Axsome Therapeutics | AXSM | New Coverage | Buy (N/A) |
63.50 (74.52) |
17.35% | Details | |
| 12/16/2020 | Concert Pharmaceuticals | CNCE | New Coverage | Buy (N/A) |
12.79 (8.37) |
-34.56% | Details | |
| 12/16/2020 | Spero Therapeutics | SPRO | New Coverage | Buy (N/A) |
17.40 (1.64) |
-90.57% | Details | |
| 12/16/2020 | Aldeyra Therapeutics | ALDX | New Coverage | Buy (N/A) |
6.89 (4.09) |
-40.64% | Details | |
| 12/16/2020 | Aprea | APRE | New Coverage | Buy (N/A) |
29.73 (5.44) |
-81.7% | Details |
